文献速递技术与安全神经MRPET

钆对比剂对68Ga-DOTATOC PET/MRI中基于CAIPI加速T1加权Dixon 3D-VIBE序列衰减校正的影响

Comparison of pre- and post-contrast-enhanced attenuation correction using a CAIPI-accelerated T1-weighted Dixon 3D-VIBE sequence in 68Ga-DOTATOC PET/MRI.
PubMed 文献 · Eur J Radiol · 2021-04-15

该研究纳入51例神经内分泌肿瘤患者,比较注射钆对比剂前后基于CAIPI加速Dixon-VIBE序列生成的衰减校正图及重建PET的SUV差异。结果显示脂肪组织和肺组织SUVmax出现显著变化,提示对比剂影响衰减校正图并进而影响PET定量,建议PET/MRI分期协议应在注射对比剂前采集衰减校正图。

要点

  • 注射钆对比剂后脂肪和肺组织SUVmax显著改变,PET定量受影响。
  • 衰减校正图应在注射对比剂前采集,以保证定量准确性。
  • 阅片时需注意对比剂对PET/MRI定量解读的潜在影响。

诊断标准与关键数值

  • 肾周脂肪SUVmax差异19.65±48.03%(p<0.0001)。
  • 腋窝脂肪SUVmax差异17.46±63.67%(p<0.0001)。
  • L4水平背部皮下脂肪SUVmax差异10.26±25.29%(p<0.0001)。
  • 肺尖部SUVmax差异5.80±10.53%(p<0.0001)。
  • 肺动脉干水平背侧肺SUVmax差异15.04±19.09%(p<0.0001),肺底背侧SUVmax差异51.27±147.61%(p<0.0001)。

局限性

  • 单中心研究,样本量有限(51例)。
  • 仅评估了特定序列和示踪剂,结论外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To investigate the influence of contrast agent administration on attenuation correction (AC) based on a CAIPIRINHA (CAIPI)-accelerated T1-weighted Dixon 3D-VIBE sequence in 68Ga-DOTATOC PET/MRI.

MATERIAL AND METHODS: Fifty-one patients with neuroendocrine tumors underwent whole-body 68Ga-DOTATOC PET/MRI for tumor staging. Two PET reconstructions were performed using AC-maps that were created using a high-resolution CAIPI-accelerated Dixon-VIBE sequence with an additional bone atlas and truncation correction using the HUGE (B0 homogenization using gradient enhancement) method before and after application of Gadolinium (Gd)-based contrast agent. Standardized uptake values (SUVs) of 21 volumes of interest (VOIs) were compared between in both PET data sets per patient. A student's t-test for paired samples was performed to test for potential differences between both AC-maps and both reconstructed PET data sets. Bonferroni correction was performed to prevent α-error accumulation, p < 0.0024 was considered to indicate statistical significance.

RESULTS: Significant quantitative differences between SUVmax were found in the perirenal fat (19.65 ± 48.03 %, p < 0.0001), in the axillary fat (17.46 ± 63.67 %, p < 0.0001) and in the dorsal subcutaneous fat on level of lumbar vertebral body L4 (10.26 ± 25.29 %, p < 0.0001). Significant differences were also evident in the lungs apical (5.80 ± 10.53 %, p < 0.0001), dorsal at the level of the pulmonary trunk (15.04 ± 19.09 %, p < 0.0001) and dorsal in the basal lung (51.27 ± 147.61 %, p < 0.0001).

CONCLUSION: The administration of (Gd)-contrast agents in this study has shown a considerable influence on the AC-maps in PET/MRI and, consequently impacted quantification in the reconstructed PET data. Therefore, dedicated PET/MRI staging protocols have to be adjusted so that AC-map acquisition is performed prior to contrast agent administration.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Bruckmann NM, Lindemann ME, Grueneisen J, et al. Comparison of pre- and post-contrast-enhanced attenuation correction using a CAIPI-accelerated T1-weighted Dixon 3D-VIBE sequence in 68Ga-DOTATOC PET/MRI. Eur J Radiol. 2021. PMID: 33892276. doi:10.1016/j.ejrad.2021.109691

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。